Vanta Bioscience has had its application to reclassify promoters Dr. Vyasmurti Madhavrao Shingatgeri and Mr. Pradeep Chowdary Veeramachineni as public shareholders rejected by BSE.

This maintains the current promoter and public shareholding status, which could affect the company’s governance and control dynamics.

The decision impacts shareholders by preserving the existing ownership structure without dilution of promoter influence.